Amino acid transport system for essential amino acid supply (None)

Essential amino acid supply involves a network of membrane-bound transporter proteins that mediate the cellular uptake of indispensable dietary amino acids which organisms cannot synthesize internally. These amino acid transporters belong primarily to solute carrier families such as SLC1, SLC3/7 heterodimers, among others. They facilitate both facilitated diffusion and active transport mechanisms across plasma membranes depending on substrate specificity and energy requirements[1][2]. Key examples include: - The neutral/large neutral amino acid transporter LAT1 (SLC7A5), often overexpressed in cancers. - The alanine-serine-cysteine transporter ASCT2 (SLC1A5), important for glutamine uptake. These systems regulate intracellular availability critical for protein synthesis, cell growth signaling pathways like mTORC1 activation[6][5]. In specialized barriers like the blood-brain barrier, distinct sets of these transporters ensure delivery of essential nutrients while maintaining brain homeostasis[3]. Dysregulation contributes pathologically to cancer metabolism reprogramming[6], neurological disorders[3], diabetes mellitus[6], among others. Despite their importance as potential therapeutic targets—especially in oncology—clinical drugs directly modulating these carriers remain under development due to challenges related to selectivity and safety profiles. Biomarker-driven approaches focusing on expression patterns help guide experimental therapies aimed at disrupting pathological nutrient supply chains within tumors[6].

Other names

Amino acid transportersEssential amino acid transport systemsNeutral and basic amino acid transport complexes

Drugs targeting these molecules generally act as inhibitors blocking the uptake of essential neutral or basic amino acids into cells, thereby starving rapidly proliferating cells like cancer cells.